Cargando…
Oncolytic Activities of Host Defense Peptides
Cancer continues to be a leading source of morbidity and mortality worldwide in spite of progress in oncolytic therapies. In addition, the incidence of cancers affecting the breast, kidney, prostate and skin among others continue to rise. Chemotherapeutic drugs are widely used in cancer treatment bu...
Autores principales: | Al-Benna, Sammy, Shai, Yechiel, Jacobsen, Frank, Steinstraesser, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233454/ https://www.ncbi.nlm.nih.gov/pubmed/22174648 http://dx.doi.org/10.3390/ijms12118027 |
Ejemplares similares
-
Suppression of Soft Tissue Sarcoma Growth by a Host Defense-Like Lytic Peptide
por: Steinstraesser, Lars, et al.
Publicado: (2011) -
Host Defense Peptides as Effector Molecules of the Innate Immune Response: A Sledgehammer for Drug Resistance?
por: Steinstraesser, Lars, et al.
Publicado: (2009) -
Superficial Vein Thrombosis 21 cm Distant From the Venous Anastomosis of a Free Flap Causing Intermittent Venous Congestion
por: Al-Benna, Sammy, et al.
Publicado: (2009) -
Antimicrobial Host Defensins – Specific Antibiotic Activities and Innate Defense Modulation
por: Ulm, Hannah, et al.
Publicado: (2012) -
Brachial neuropathy 22 years after radiation therapy for fibrosarcoma: a case report
por: Al-Benna, Sammy, et al.
Publicado: (2009)